Here is Lydia Warburton’s (SCGH Medical Oncology Fellow) talk on the benefits and adverse effects of immunotherapy in oncology patients. Here is Julie Teraci’s (CNC Wa Melanoma Advisory Service) complimentary talk on managing adverse effects of immunotherapy treatment. Resources: Management…
Here is a Medical Practice Guideline on the MANAGEMENT OF IMMUNE RELATED ADVERSE EVENTS ASSOCIATED WITH USE OF IMMUNE CHECKPOINT INHIBITORS produced by Dr Jack Burke (Immunology Department, FSH), currently pending approval at SCGH. Date implemented – 05/2017 Review date – 05/2020…
SCGH management guideline for febrile neutropenia Date implemented – 05/2010 Review date – Pending (checked 2/2016) Author – David Speers (Infectious diseases) / Haematology
Indications Diagnostic Determine the cause of new onset ascites, ascites of unknown origin, or suspected malignant ascites Suspicion of bacterial peritonitis in a patient with known ascites with associated pyrexia, hypotension, tachycardia or encephalopathy. Therapeutic Remove excess intraperitoneal fluid to…
Here is Vera’s talk on paraneoplastic syndromes
